U.S. Naloxone Market Growth Accelerated by Widening Adoption of Naloxone



 Naloxone is an opioid antagonist prescribed to treat narcotic overdose emergencies and reduce opioid withdrawal symptoms. It works by reversing the effects of opioid drugs and can help bring someone back to a conscious breathing state and prevent death. The naloxone market has been witnessing a surge in demand due to rising prevalence of opioid abuse and addiction cases in the U.S. Naloxone products are now available in nasal spray and auto-injector forms to enable quick administration by bystanders and non-medical users during an overdose emergency. The global U.S. Naloxone Market is estimated to be valued at US$ 1,390.7 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The increasing rate of opioid addiction and overdose cases has led various government and non-profit organizations to take initiatives to encourage naloxone adoption as part of overdose prevention programs. Many states have enacted Good Samaritan laws and third-party prescribing regulations allowing pharmacists to dispense naloxone products without an individual prescription for an opioid overdose victim. This has significantly improved public access and availability of naloxone over-the-counter to help address opioid crisis. Technological advancements have also led to development of easy-to-administer naloxone delivery formats like nasal spray and auto-injectors that can prove vital for saving lives in an overdose emergency.

Segment Analysis

The U.S. naloxone market is dominated by the injectable segment due to the greater efficacy and faster onset of action of injectable naloxone as compared to other formulations such as nasal spray and auto-injector. Injectable naloxone can be administered intramuscularly or intravenously and provides faster reversal of opioid overdose within 2 to 5 minutes. This makes injectable naloxone highly preferred by first responders such as paramedics and emergency medical technicians for emergency situations.

Key Takeaways
The global U.S. naloxone market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is anticipated to reach US$ 1,390.7 Mn by 2024, expanding at a CAGR of 10%.

Regional analysis: The northeast region holds the dominating share in the U.S. naloxone market currently due to higher prevalence of opioid overdose deaths. States like New York and Massachusetts have implemented Good Samaritan laws that provide legal protection to those who report or experience an overdose. This has encouraged the use and administration of naloxone kits in the region. Moreover, higher adoption of naloxone prescriptions in pharmacies and hospitals is driving the market growth.

Key players operating in the U.S. naloxone market are Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., Kern Pharma, S.L., Samarth Life Sciences Pvt. Ltd., Opiant Pharmaceuticals, Pfizer, Sandoz, and Amneal Pharmaceuticals. Mylan N.V. holds a dominant share with its naloxone auto-injector and nasal spray products.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more